Evidence map›Paper›PMID 28389562›Full record

ArticleThe Journal of biological chemistry2017

Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts.

Shibnath Ghatak, Roger R Markwald, Vincent C Hascall, William Dowling, Robyn Grayson Lottes, John E Baatz, Gyada Beeson, Craig C Beeson, Mark A Perrella, Victor J Thannickal and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shibnath GhatakFrom the Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina 29425, ghatak@musc.edu.
Roger R MarkwaldFrom the Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina 29425.
Vincent C Hascallthe Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195.
William DowlingFrom the Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina 29425.
Robyn Grayson Lottesthe Departments of Pediatrics-Neonatology and.
John E Baatzthe Departments of Pediatrics-Neonatology and.
Gyada BeesonDrug Discovery and Biomedical sciences, Medical University of South Carolina, Charleston, South Carolina 29425.
Craig C BeesonDrug Discovery and Biomedical sciences, Medical University of South Carolina, Charleston, South Carolina 29425.
Mark A Perrellathe Division of Pulmonary and Critical Care Medicine, Department of Medicine, and the Department of Pediatric Newborn Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, and.
Victor J Thannickalthe Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006.
Suniti MisraFrom the Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina 29425, misra@musc.edu.
Medical University of South Carolina · USBrigham and Women's Hospital · USCleveland Clinic · USCollege of Charleston · USUniversity of Alabama at Birmingham · US

Funding

South Carolina IDeA Networks of Biomedical Research (SC INBRE V)P20GM103499 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EDIE C GOLDSMITH · 2012 to 2026
$61.0M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
VERSICAN PROTEOLYSIS AND REGULATION OF VASCULAR SMOOTH MUSCLEP01HL107147 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI LAUER, MARK E · 2011 to 2017
$16.1M
Targeted Nano-therapeutics for Neural RegenerationP20GM103444 · NIGMS · CLEMSON UNIVERSITY · PI MARKWALD, ROGER R, VYAVAHARE, NAREN R · 2012 to 2018
$14.9M
SC COBRE for Developmentally Based Cardiovascular DiseasesP30GM103342 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KERN, MICHAEL J · 2012 to 2016
$5.5M
RESEARCH PILOT PROJECTS PROGRAMP30GM103339 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGRETMEN, BESIM · 2012 to 2016
$5.4M
MUCOPOLYSACCHRIDE METABOLISM IN CARDIAC ANOMALIESR01HL033756 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 1985 to 2015
$4.8M
TSG-6: Novel Regulator of Viral-Induced Hyaluronan Synthesis in Inflamed AirwaysR01HL113325 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2013 to 2017
$1.6M
Silencing CD44v6 Expression Prevents Intestinal Tumor GrowthR03CA167722 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MISRA, SUNITI · 2013 to 2014
$147k
NCI NIH HHS R03 CA167722NHLBI NIH HHS P01 HL107147NHLBI NIH HHS R01 HL033756NHLBI NIH HHS R01 HL113325NIGMS NIH HHS P20 GM103444NIGMS NIH HHS P20 GM103499NIGMS NIH HHS P20 GM103542NIGMS NIH HHS P30 GM103339NIGMS NIH HHS P30 GM103342
6 · The paper itself

Abstract

The appearance of myofibroblasts is generally thought to be the underlying cause of the fibrotic changes that underlie idiopathic pulmonary fibrosis. However, the cellular/molecular mechanisms that account for the fibroblast-myofibroblast differentiation/activation in idiopathic pulmonary fibrosis remain poorly understood. We investigated the functional role of hyaluronan receptor CD44V6 (CD44 containing variable exon 6 (v6)) for differentiation of lung fibroblast to myofibroblast phenotype. Increased hyaluronan synthesis and CD44 expression have been detected in numerous fibrotic organs. Previously, we found that the TGFβ1/CD44V6 pathway is important in lung myofibroblast collagen-1 and α-smooth-muscle actin synthesis. Because increased EGR1 (early growth response-1) expression has been shown to appear very early and nearly coincident with the expression of CD44V6 found after TGFβ1 treatment, we investigated the mechanism(s) of regulation of CD44V6 expression in lung fibroblasts by TGFβ1. TGFβ1-mediated CD44V6 up-regulation was initiated through EGR1 via ERK-regulated transcriptional activation. We showed that TGFβ1-induced CD44V6 expression is through EGR1-mediated

Indexed as

MAP Kinase Signaling SystemAnimalsEarly Growth Response Protein 1Gene Expression RegulationGlucuronosyltransferaseHyaluronan ReceptorsHyaluronan SynthasesHyaluronic AcidLungMiceMitogen-Activated Protein Kinase 3MyofibroblastsPulmonary FibrosisTransforming Growth Factor beta1CD44v6 antigenEarly Growth Response Protein 1Egr1 protein, mouseGlucuronosyltransferaseHas2 protein, mouseHyaluronan ReceptorsHyaluronan SynthasesHyaluronic AcidMitogen-Activated Protein Kinase 3Tgfb1 protein, mouseTransforming Growth Factor beta1AP-1 transcription factor (AP-1)CD44early growth response protein 1 (EGR1)extracellular-signal-regulated kinase (ERK)signaling

Identifiers

PMID28389562
PMCPMC5481558
OpenAlexW2604886951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.